Health Canada — Medical Devices · Canada · 2026-06-24 · Type II
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Reported risk: Boston Scientific is initiating a voluntary removal of unused Infinion™ CX Leads as part of the planned transition to the next generation lead (Infinion Pro). this action does not affect the devices that have already been implanted. For leads already in use, continued routine follow-up is recommended.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.